March 10, 2017 12:00am

Financial results also known as (AKA) earnings is a ‘scorecard’ of public stem, cell, gene and regenerative therapy's companies.

 

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.


COMPANY SYMBOL NET INCOME Q4/16 LOSS Q4/16 LPS Q4/16 CASH 
Aduro Biotech, Inc. ADRO   -$29.6 M -$0.44 $361.9 M
Applied Genetic Technologies AGTC +$2.1 M   +$0.11 $159.1 M
Asterias Biotherapeutics AST   -$9.3 M -$0.20 $19.9 M
Athersys, Inc. ATHX   -$7.1 M -$0.10 $34.7 M
Adverum Biotechnologies, Inc. ADVM   -$22.4 M -$0.54 $222.2 M
AxoGen, Inc. AXGN   -$3.2 M -$0.10 $30 M
Bellicum Pharmaceuticals, Inc. BLCM   -$19.9 M -$0.74 $113.4 M
BioLife Solutions, Inc. BLFS   -$3.3 M -$0.26 $1.4 M
Biostage, Inc. BSTG   -$3.34 M -$0.20 $2.94 M
BioTime, Inc. BTX   -$5.1 M -$0.05 $22.1 M
bluebird bio BLUE   -$71.33 M -$1.88 $884.8 M
Brainstorm Cell Therapeutics Inc. BCLI   FY16 --$5 M -$0.27 $10 M
Caladrius Biosciences. CLBS   -$6 M -$0.73

$14.7 M

$75 M from PCT sale

Capricor CAPR   -$4.5 M -$0.21 $16.2 M
Cellectis CLLS  

-€12.5 M

-€0.35

€276.2 M

Cesca Therapeutics, Inc KOOL   -$3.4 M N/A $4.89 M
Cytori Therapeutics, Inc. CYTX   -$4.9 M -$0.24 $12.6 M
Fate Therapeutics, Inc. FATE   -$7.94 M -$0.21 $92.1 M
Fibrocell Science, Inc. FCSC   -$15.29 M (FY16) -$0.39 (FY16) $17.5 M
Histogenics Corporation HSGX   -$11.1 M -$0.61 (diluted) $31.9 M
ImmunoCellular Therapeutics, Ltd. IMUC   -$6.3 M -$1.36 $11.4 M
International Stem Cell ISCO   FY16 -$10 M -$0.34 $110 K
Intrexon Corporation XON   -$44.1 M -$0.26 $243.2 M
Juno Therapeutics, Inc. JUNO   -$52.8 M -$0.51 $922.3 M
Kite Pharma, Inc. KITE   -$84.9 M -$1.70 $414.4 M
Mesoblast Limited MBLTY   -$20.5 M -$5.27 $55.6 M
MiMedx Group, Inc MDXG +$5.5 M   +$0.05 $34.4 M
Neuralstem, Inc.  CUR   FY16 -$21.1 M -$2.53 $20.2 M
Northwest Biotherapeutics, Inc. NWBO        
Opexa Therapeutic, Inc. OPXA   FY16 -$7.9 M -$1.13 $3.44 M
Organovo Holdings, Inc. ONVO        
Osiris Therapeutics, Inc. OSIR   N/A N/A N/A
Pluristem Therapeutics, Inc. PSTI   -$6.5 M -$0.08  
ReNeuron Group PLC RENE.L        
Regenxbio RGNX   -$19.6 M -$0.74 $159 M
Sangamo Biosciences, Inc. SGMO   -$9.6 M -$0.14 $142.8 M
Spark Therapeutics, Inc. ONCE   -$123.7 M -$4.29 $333.1 M
Stemline Therapeutics, Inc. STML   -$10 M -$0.56 $67.6 M
uniQure N.V. QURE   -$14.7 M  
Verastem, Inc. VSTM   FY16 -$36.4 M -$0.99 $80.9 M
Vericel Corporation VCEL   -$6.2 M -$0.34 $23 M
VistaGen Therapeutics, Inc. VTGN